Reverse and Forward Translational Neuropharmacology in Psychiatric Drug Discovery
The probability of achieving marketing approval of a novel therapeutic for psychiatric indications is extremely low due largely to the inability to demonstrate durable and reproducible efficacy in phase II trials and beyond. These failures are often attributed to the lack of translation of the under...
Gespeichert in:
| Veröffentlicht in: | Clinical pharmacology and therapeutics 2018-02, Vol.103 (2), p.193-195 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!